CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Shandong Wohua Pharmaceutical Co Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Shandong Wohua Pharmaceutical Co Ltd
No. 3517 Liyuan Street
Hi-Tech Industrial Development Zone
Phone: +86 5368553373p:+86 5368553373 WEIFANG, SDG  261205  China Ticker: 002107002107
Business Summary
Shandong Wohua Pharmaceutical Co Ltd is a China-based company primarily engaged in the research, development, production and sale of Chinese patent medicines. The Company's cardiovascular and nervous system drug products include Wohua Xinkeshu Tablets, Hedan Tablets and Capsules, Naoxueshu Oral Liquid, Tongluo Huatan Capsules, Shenzhiling Oral Liquid and others. The Company's musculoskeletal system drug products include Gushukang Capsules and Granules, Yuandu Hanbi Liquid and others. The Company's reproductive and urinary system drug products include Hupoxiaoshi Granules and others. The Company's respiratory system drug products include Xiaoer Tuire Granules, Fufang Xiling Jiedu Tablets, Yuandu Ganmao Granules, Yinhuang Granules and others. The Company mainly conducts its business in the domestic market.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-Yes---

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
3/31/202512/31/2023Yes----

Industries
SIC Code Description
2834 Pharmaceutical preparations
2833 Medicinal chemicals and botanical products
5122 Drugs, drug proprietaries, and druggists' sundries

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board BingxianZhao 61 10/25/2024 2/1/2002
President ShengtingLi 56 2/10/2025 2/11/2022
Vice Chairman of the Board CaixiaZhao 54 4/26/2024
8 additional Officers and Directors records available in full report.

Business Names
Business Name
002107
Shandong Wohua Pharmaceutical Co., Ltd.

General Information
Number of Employees: 1,353 (As of 12/31/2023)
Outstanding Shares: 577,209,600 (As of 3/31/2025)
Shareholders: 39,116
Stock Exchange: SHE
Fax Number: +86 5368553373


Copyright © 2025 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, May 23, 2025